Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue: +4.15%
EPS: +49.0%
Free cash flow: +49.8%
Total debt: +80.0%

Quarter to September 2026, against a year earlier

213.33 5.33 +2.56%

Follow ILMN

Alert me

Market cap: $31.5B
P/E: 35.6×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 8/9
Altman Z: 4.39
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Illumina, Inc. 10-Q filed Oct 30, 2026

Fiscal Q3 2026 · Period ended Sep 27, 2026 · Filed Oct 30, 2026 · accepted 4:14 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Previous quarter Same quarter last year

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 31, 2025: no comparison — the Item was not found